UnitedHealth Group Incorporated $UNH Shares Purchased by Insigneo Advisory Services LLC

Insigneo Advisory Services LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 35.9% during the 2nd quarter, Holdings Channel.com reports. The fund owned 8,037 shares of the healthcare conglomerate’s stock after acquiring an additional 2,124 shares during the period. Insigneo Advisory Services LLC’s holdings in UnitedHealth Group were worth $2,507,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in UNH. Nuveen LLC acquired a new position in UnitedHealth Group in the first quarter valued at $3,846,764,000. Vanguard Group Inc. lifted its stake in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the last quarter. Davis Selected Advisers increased its position in UnitedHealth Group by 2,234.9% during the 2nd quarter. Davis Selected Advisers now owns 1,132,885 shares of the healthcare conglomerate’s stock worth $353,426,000 after purchasing an additional 1,084,366 shares in the last quarter. Finally, National Bank of Canada FI lifted its position in UnitedHealth Group by 137.8% during the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock worth $859,518,000 after buying an additional 950,928 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

UNH opened at $319.40 on Monday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $622.83. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The company’s 50-day moving average price is $344.69 and its 200 day moving average price is $315.86. The firm has a market cap of $289.32 billion, a price-to-earnings ratio of 16.67, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the firm posted $7.15 earnings per share. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

Analyst Ratings Changes

A number of research analysts recently weighed in on UNH shares. Wells Fargo & Company lifted their target price on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a report on Tuesday, October 7th. Piper Sandler cut their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 28th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Mizuho increased their price objective on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Finally, Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Eighteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.